Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia
Top Cited Papers
- 28 September 2017
- journal article
- review article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 131 (19), 2451-2468
- https://doi.org/10.1042/cs20160727
Abstract
Increasing evidence suggests that vascular risk factors contribute to neurodegeneration, cognitive impairment and dementia. While there is considerable overlap between features of vascular cognitive impairment and dementia (VCID) and Alzheimer’s disease (AD), it appears that cerebral hypoperfusion is the common underlying pathophysiological mechanism which is a major contributor to cognitive decline and degenerative processes leading to dementia. Sustained cerebral hypoperfusion is suggested to be the cause of white matter attenuation, a key feature common to both AD and dementia associated with cerebral small vessel disease (SVD). White matter changes increase the risk for stroke, dementia and disability. A major gap has been the lack of mechanistic insights into the evolution and progress of VCID. However, this gap is closing with the recent refinement of rodent models which replicate chronic cerebral hypoperfusion. In this review, we discuss the relevance and advantages of these models in elucidating the pathogenesis of VCID and explore the interplay between hypoperfusion and the deposition of amyloid β (Aβ) protein, as it relates to AD. We use examples of our recent investigations to illustrate the utility of the model in preclinical testing of candidate drugs and lifestyle factors. We propose that the use of such models is necessary for tackling the urgently needed translational gap from preclinical models to clinical treatments.Keywords
This publication has 144 references indexed in Scilit:
- Mechanisms of sporadic cerebral small vessel disease: insights from neuroimagingThe Lancet Neurology, 2013
- Oxidative stress and cerebral endothelial cells: Regulation of the blood–brain-barrier and antioxidant based interventionsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarctsActa Neuropathologica, 2011
- The projected effect of risk factor reduction on Alzheimer's disease prevalenceThe Lancet Neurology, 2011
- Age-associated reductions in cerebral blood flow are independent from regional atrophyNeuroImage, 2011
- Cerebral amyloid angiopathy pathology and cognitive domains in older personsAnnals of Neurology, 2010
- Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodiesActa Neuropathologica, 2010
- Cilostazol, a Phosphodiesterase Inhibitor, Attenuates Photothrombotic Focal Ischemic Brain Injury in Hypertensive RatsJournal of Cerebral Blood Flow & Metabolism, 2009
- Age-related slowing of memory retrieval: Contributions of perceptual speed and cerebral white matter integrityNeurobiology of Aging, 2008
- Mucosal Tolerization to E-Selectin Protects against Memory Dysfunction and White Matter Damage in a Vascular Cognitive Impairment ModelJournal of Cerebral Blood Flow & Metabolism, 2007